Summary by Moomoo AI
SINDA BIOPHARMACEUTICAL CO., LTD. WILL HOLD ITS ANNUAL GENERAL MEETING ON JUNE 21, 2024 AT THE SITE OF SINDA BIO ADMINISTRATION BUILDING IN SUZHOU INDUSTRIAL PARK, CHINA. The meeting will include the adoption of the 2023 audited financial statements, directors' and auditors' reports, and the re-election of such directors as Zhang Qian, Lu Shun, Chen Kaixin, Xu Yi-yin and Chen Shuyun. In addition, the meeting will authorize the Board of Directors to determine the remuneration of directors, to renew diligent accountants as acting auditors, and to consider ordinary resolutions regarding share repurchases and issuance. The Special Resolution includes the approval of the Company's Articles of Association and Conditions, which have been amended and revised for the 15th time. Shareholders will vote on all resolutions by vote and submit proxy forms 48 hours prior to the meeting. Share transfer registration will be suspended from 18 to 21 June 2024.